BUZZ-Disc Medicine dives as FDA declines to approve rare disease drug
Reuters
Feb 14
BUZZ-<a href="https://laohu8.com/S/IRON">Disc Medicine</a> dives as FDA declines to approve rare disease drug
** Disc Medicine's IRON.O shares down 28.4% at $51.3
** Blood disease-focused biopharma says U.S. FDA has declined to approve Bitopertin, its rare genetic disorder treatment
** Bitopertin has been under review for accelerated approval and as part of the Commissioner's National Priority Voucher pilot program
** FDA indicated a need to see the results of the ongoing late-stage APOLLO study before making a decision - IRON
** Topline data from APOLLO study expected in Q4
** Including session losses, stock down roughly 41% YTD
(Reporting by)
((mrinalika.roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.